Clemondo Group AB (publ) (STO:CLEM)
Sweden · Delayed Price · Currency is SEK 6.10
+0.12 (2.01%)
Nov 3, 2026, 5:29 PM CET
Clemondo Group AB Financials Overview
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 301.71 | 291.21 | 262.06 | 278.9 | 299.2 | 301.53 |
Revenue Growth | 9.27% | 11.12% | -6.04% | -6.79% | -0.77% | -16.04% |
Gross Profit Gross Profit Growth | 119.05 | 112 | 97.56 | 100.62 | 99.49 | 122.9 |
Operating Income Operating Income Growth | 7.05 | 9.4 | 9.54 | 16.43 | 7.47 | 25.38 |
Net Income Net Income Growth | 3.68 | 5.51 | 6.17 | 9.96 | 3.76 | 17.02 |
Earnings Per Share EPS Growth | 0.27 | 0.40 | 0.45 | 0.72 | 0.28 | 1.28 |
EPS Growth | -49.93% | -10.78% | -38.04% | 160.18% | -78.45% | -54.19% |
Fiscal Year | TTM | FY 2025 | FY 2024 |
|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 |
Vehicles Vehicles Growth | 97.78 | 93.48 | 86.88 |
Medical Care Medical Care Growth | 116.45 | 109.79 | 92.91 |
Industry Industry Growth | 26.72 | 27.3 | 21.88 |
Contractual Manufacturing Contractual Manufacturing Growth | 60.76 | 60.63 | 60.4 |
Total Total Growth | 301.71 | 291.21 | 262.06 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 0 | 0 | 0 | 1.13 | 0 | 1.09 |
Total Debt Total Debt Growth | 53.18 | 47.11 | 22.46 | 29.67 | 53.03 | 65.13 |
Net Cash (Debt) Net Cash Growth | -53.18 | -47.11 | -22.46 | -28.54 | -53.03 | -64.04 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -3.84 | -3.40 | -1.62 | -2.06 | -3.89 | -4.73 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 5.63 | 14.04 | 9.82 | 27.2 | 9.1 | 28.23 |
Capital Expenditures CapEx Growth | -0.41 | -0.34 | -1.89 | -0.29 | -0.49 | -1.1 |
Free Cash Flow Free Cash Flow Growth | 5.21 | 13.7 | 7.94 | 26.91 | 8.61 | 27.13 |
Free Cash Flow Growth | -48.00% | 72.67% | -70.51% | 212.66% | -68.28% | -57.75% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 39.46% | 38.46% | 37.23% | 36.08% | 33.25% | 40.76% |
Operating Margin | 2.34% | 3.23% | 3.64% | 5.89% | 2.50% | 8.42% |
Pretax Margin | 1.41% | 2.51% | 3.11% | 4.72% | 1.57% | 7.10% |
Profit Margin | 1.22% | 1.89% | 2.35% | 3.57% | 1.26% | 5.64% |
FCF Margin | 1.73% | 4.71% | 3.03% | 9.65% | 2.88% | 9.00% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 22.97 | 22.14 | 15.22 | 12.38 | 30.53 | 11.62 |
Forward PE | 23.46 | 13.09 | 8.22 | 7.91 | 15.81 | 13.33 |
P/FCF Ratio | 16.20 | 8.89 | 11.83 | 4.58 | 13.35 | 7.29 |
PS Ratio | 0.28 | 0.42 | 0.36 | 0.44 | 0.38 | 0.66 |